Richard Whitcomb — President and CEO. Rick’s background is in operations, services, and finance. Prior to joining BiOptix, Rick was Senior Manager of the On Site Services business for Agilent Technologies Electronic Measurement Group. His background also includes several years of Corporate Development experience for Agilent and Hewlett-Packard Co., and he was formerly Operational CFO for the Communications Network Solutions business unit at Agilent. Rick brings substantial international experience, having spent five years living and working in Europe for Agilent and Hewlett-Packard Co. During his career, he has worked with scientists in Agilent Labs and HP Labs to move promising new technologies from the lab into commercialization, and ultimately into the hands of customer. Rick holds a Master of Science in Finance and Econometrics from The University of Colorado and a Bachelor of Science in Economics from The University of Minnesota.
Dr. Scott Klakamp — Vice President of Chemistry & Biochemistry. Scott is one of the leading scientists in utilizing Surface Plasmon Resonance, KinExA®, and FACS techniques to measure the binding kinetics and equilibrium constants of human monoclonal antibody/antigen complexes and biosensor technology in general. Scott was the Founder and Principal Consultant of SKD Consulting LLC. Prior to SKD Consulting LLC, he was a Senior Research Fellow at Takeda San Francisco, Inc. He led the Biophysical Chemistry and Research Informatics Groups and has extensive experience in research and development involving the biophysical and analytical characterization of biologics and specifically monoclonal antibodies. He also served as a Principal Scientist II at AstraZeneca R&D Hayward (merged with MedImmune, Inc), where he led the Biophysical Characterization Group prior to joining Takeda San Francisco. Prior to AstraZeneca, he headed the Biophysical Group at Abgenix, Inc. (acquired by Amgen, Inc.) from 2001-2006, and previously held scientific positions at Chiron, Inc., GeneMedicine, Inc, and the Pennsylvania State Police. Dr. Klakamp has been an author on over 30 research and review papers, book chapters, and patents, and has been an invited speaker at numerous international and national meetings. He received his B.A. in Chemistry from Houghton College and his PhD in Chemistry at the Pennsylvania State University. From 1990 to 1993, he completed a postdoctoral fellowship (funded by a National Research Service Award from the National Institutes of Health) at the California Institute of Technology in bioinorganic chemistry.
Ken Dickerson — Vice President of Sales. Ken comes to BiOptix having been in the real time label free technologies spanning molecular to cellular analysis for over 15 years. Prior to leaving ACEA Biosciences as National Sales Director and joining BiOptix Ken held key leadership roles with several biosensor companies which included Biacore, Axela, and Silicon Kinetics. Ken obtained his strong scientific background having spent many years in basic research at the Burnham Institute (formerly La Jolla Cancer Research Institute) and the American Red Cross Jerome Holland Labs. Ken brings sales and marketing experience in both the North American and International markets. He holds a BS in Cell Biology and Biochemistry from the University of California San Diego. Ken holds several patents and is co-author of multiple peer-reviewed journal articles.
Ken Wilczek — Vice President of Worldwide Marketing & Business Development. In addition to senior leadership and consulting roles both inside and outside of life sciences, prior to joining BiOptix, Ken was General Manager, Research Antibodies for Thermo Fisher Scientific. In this role, Ken had commercial responsibility for the Thermo Scientific antibody and high content analysis businesses and led the integration of ABR—Affinity BioReagents into the company post-acquisition. Prior to joining Thermo Fisher Scientific, Ken was the President of ABR—Affinity BioReagents, a manufacturer of research antibodies and custom antibody solutions. Ken was instrumental in growing the company and led the expansion of both the product line as well as global sales channels, ultimately positioning the company for divestment in 2008. Ken was also the General Manager for IHS Health Group and related divisions, a SaaS publisher to the life science, medical device and pharmaceutical industries. In addition, Ken held general management roles at Johnson & Johnson, focusing on international market and business development. Ken holds a Master of International Management degree from Thunderbird School of Global Management and a Bachelor of International Business Administration from The University of Denver.
Dr. Slava Petropavlovskikh — Director of Research and Development, Co-Founder, BiOptix. Slava is a dual degree graduate in Applied Mathematics (M.S. – Military Academy) and Applied Physics (M.S. – Moscow Institute of Physics and Technology, Moscow, Russia, Aerospace Department). He is a published expert and patent holder in applied physics, optical effects and signal manipulation and a former Science and Technology Manager at Ionics Sievers.
Kevin Ryan — Director of Engineering. Kevin brings over thirteen years of engineering experience to BiOptix. His expertise is in mechanical design, modeling, simulation and product development. Prior to joining BiOptix, Kevin focused on testing for aerospace applications with an emphasis on cryogenic temperatures. He has published papers on topics ranging from microcrack fracture toughness to bioaerosol inactivation using irradiation. Kevin holds both a Master of Science and a Bachelor of Science in Mechanical Engineering from the University of Colorado, Boulder.